Nam-Chun Cho

Private Equity Investor at

Aju IB Investment Co., Ltd. (Private Equity)

60 year

Finance

Health Technology

Profile

Mr. Nam-Chun Cho is Executive Director at Aju IB Investment Co., Ltd. Previously he worked at Korea Investors Services, Inc. He graduated Kyunghee University.

Nam-Chun Cho active positions

Companies	Position	Start
Aju IB Investment Co., Ltd. (Private Equity) Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification.	Private Equity Investor	2007-12-31

All active positions of Nam-Chun Cho

Former positions of Nam-Chun Cho

Companies	Position	End
OSANG HEALTHCARE CO.,LTD	Director/Board Member	-

See the detail of Nam-Chun Cho's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nam-Chun Cho's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Aju IB Investment Co., Ltd. (Private Equity) Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification.	Finance
Osang Healthcare Co., Ltd. Osang Healthcare Co., Ltd. Medical SpecialtiesHealth Technology Develops blood glucose & biochemical meters and immunodiagnostic systems	Health Technology

Private companies

Finance